Acumen Pharmaceuticals (ABOS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Acumen Pharmaceuticals Revenue Highlights


00

Acumen Pharmaceuticals Revenue by Period


Acumen Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$1.44M-15.38%
2019-12-31$1.70M-

Acumen Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Acumen Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$290.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$1.44M96.71%
2020-09-30$730.00K383.44%
2020-06-30$151.00K-33.19%
2020-03-31$226.00K-

Acumen Pharmaceuticals generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Acumen Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$88.64M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
XFORX4 Pharmaceuticals-$563.00K
DAWNDay One Biopharmaceuticals-$8.19M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--

ABOS Revenue FAQ


Acumen Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ABOS's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

Acumen Pharmaceuticals's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $290K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). ABOS's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

Acumen Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.